13.59
price up icon3.27%   0.43
after-market Handel nachbörslich: 13.59
loading

Kalvista Pharmaceuticals Inc Aktie (KALV) Neueste Nachrichten

pulisher
01:41 AM

KalVista Pharmaceuticals Inc. stock volume spike explainedJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser

01:41 AM
pulisher
01:18 AM

Can technical indicators confirm KalVista Pharmaceuticals Inc.’s reversalJuly 2025 Update & Low Drawdown Trading Techniques - Newser

01:18 AM
pulisher
Aug 27, 2025

Price action breakdown for KalVista Pharmaceuticals Inc.2025 Macro Impact & AI Driven Stock Movement Reports - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Real time social sentiment graph for KalVista Pharmaceuticals Inc.July 2025 Pullbacks & Weekly High Return Opportunities - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

KalVista Pharmaceuticals (KALV): Assessing the Technical Bull Case Amid Mixed Short-Term Signals - AInvest

Aug 27, 2025
pulisher
Aug 27, 2025

KalVista Pharmaceuticals Stock Sees RS Rating Rise To 82 - Investor's Business Daily

Aug 27, 2025
pulisher
Aug 27, 2025

Is KalVista Pharmaceuticals Inc. showing signs of accumulationDip Buying & Smart Allocation Stock Reports - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

What’s the recovery path for long term holders of KalVista Pharmaceuticals Inc.July 2025 Short Interest & AI Powered Market Entry Strategies - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

How institutional ownership impacts KalVista Pharmaceuticals Inc. stockJuly 2025 Patterns & Reliable Volume Spike Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Can volume confirm reversal in KalVista Pharmaceuticals Inc.Trade Ideas & Risk Controlled Swing Trade Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

KalVista Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2025 - The Globe and Mail

Aug 27, 2025
pulisher
Aug 27, 2025

Forecasting KalVista Pharmaceuticals Inc. price range with options dataQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - Newser

Aug 27, 2025
pulisher
Aug 27, 2025

Bollinger Bands Show Potential Breakout in KalVista Pharmaceuticals Inc.IPO Watch & Intraday High Probability Setup Alerts - beatles.ru

Aug 27, 2025
pulisher
Aug 27, 2025

Stocks To Watch: KalVista Pharmaceuticals Sees RS Rating Rise To 82 - Investor's Business Daily

Aug 27, 2025
pulisher
Aug 27, 2025

Is KalVista Pharmaceuticals Inc. reversing from oversold territoryQuarterly Trade Summary & Risk Managed Investment Entry Signals - Newser

Aug 27, 2025
pulisher
Aug 26, 2025

How to build a dashboard for KalVista Pharmaceuticals Inc. stockRate Cut & Weekly Breakout Watchlists - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

KalVista Pharmaceuticals Executives Sell Shares at $13.42/Share. - AInvest

Aug 26, 2025
pulisher
Aug 26, 2025

Sentiment analysis tools applied to KalVista Pharmaceuticals IncJuly 2025 Update & Short-Term Trading Opportunity Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

KalVista Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView

Aug 26, 2025
pulisher
Aug 26, 2025

Sentiment analysis tools applied to KalVista Pharmaceuticals Inc.Rate Cut & Community Trade Idea Sharing - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Analyzing recovery setups for KalVista Pharmaceuticals Inc. investors2025 Bull vs Bear & Safe Capital Growth Tips - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

How high can KalVista Pharmaceuticals Inc. stock goCEO Change & Long-Term Safe Investment Plans - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Is KalVista Pharmaceuticals Inc. still worth holding after the dipEntry Point & Low Drawdown Trading Strategies - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Measuring KalVista Pharmaceuticals Inc.’s beta against major indicesWeekly Stock Recap & Precise Entry and Exit Recommendations - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

KalVista Pharmaceuticals Inc. At Decision Level — Rebound or Resistance getLinesFromResByArray error: size == 0 - metrotimes.co.kr

Aug 26, 2025
pulisher
Aug 26, 2025

Is this a good reentry point in KalVista Pharmaceuticals Inc.Weekly Gains Report & Risk Adjusted Buy/Sell Alerts - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

Is KalVista Pharmaceuticals Inc. forming a reversal pattern2025 Top Decliners & Technical Confirmation Trade Alerts - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Hereditary Angioedema Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies - The Globe and Mail

Aug 25, 2025
pulisher
Aug 25, 2025

Using economic indicators to assess KalVista Pharmaceuticals Inc. potentialJuly 2025 WrapUp & Fast Gain Swing Alerts - Newser

Aug 25, 2025
pulisher
Aug 23, 2025

How to use Fibonacci retracement on KalVista Pharmaceuticals Inc.Rate Cut & Daily Profit Maximizing Trade Tips - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

Can KalVista Pharmaceuticals Inc. keep up with sector leadersWeekly Trade Recap & AI Enhanced Trade Execution Alerts - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

Can KalVista Pharmaceuticals Inc. maintain sales growthFed Meeting & High Accuracy Swing Trade Signals - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

What analysts say about KalVista Pharmaceuticals Inc. stock2025 Biggest Moves & Fast Moving Stock Trade Plans - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

Is KalVista Pharmaceuticals Inc. meeting your algorithmic filter criteriaQuarterly Trade Summary & Daily Entry Point Alerts - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

Can KalVista Pharmaceuticals Inc. deliver consistent dividends2025 Market Sentiment & Growth-Oriented Investment Plans - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

What is KalVista Pharmaceuticals Inc. s 5 year growth outlookM&A Rumor & Short-Term Swing Trade Alerts - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

KalVista Pharmaceuticals Inc. At Decision Level — Rebound or Resistance2025 Bull vs Bear & Weekly High Conviction Ideas - classian.co.kr

Aug 23, 2025
pulisher
Aug 22, 2025

Institutional scanner results for KalVista Pharmaceuticals Inc.Weekly Trading Summary & Community Driven Trade Alerts - Newser

Aug 22, 2025
pulisher
Aug 22, 2025

Applying Elliott Wave Theory to KalVista Pharmaceuticals Inc.Options Play & Free Expert Verified Stock Movement Alerts - Newser

Aug 22, 2025
pulisher
Aug 22, 2025

KalVista Pharmaceuticals Announces 2026 Annual Meeting of Stockholders - AInvest

Aug 22, 2025
pulisher
Aug 21, 2025

Momentum Traders Eye KalVista Pharmaceuticals Inc. for Quick BounceBull Run & Low Risk High Win Rate Stock Picks - beatles.ru

Aug 21, 2025
pulisher
Aug 21, 2025

KalVista Pharmaceuticals sets June 2026 date for next annual stockholder meeting - Investing.com

Aug 21, 2025
pulisher
Aug 21, 2025

KalVista Pharmaceuticals Updates Stockholder Meeting Schedule - TipRanks

Aug 21, 2025
pulisher
Aug 19, 2025

Yea Christopher, KalVista Pharmaceuticals chief development officer, sells $34k in stock - Investing.com

Aug 19, 2025
pulisher
Aug 19, 2025

KalVista Pharmaceuticals Executives Sell Shares at $13.19/Share on August 18, 2025. - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Kalvista pharma CMO Audhya sells $38k in shares - Investing.com

Aug 19, 2025
pulisher
Aug 19, 2025

Intraday pattern recognizer results for KalVista Pharmaceuticals Inc.July 2025 Retail & Accurate Trade Setup Notifications - Newser

Aug 19, 2025
pulisher
Aug 17, 2025

Does KalVista Pharmaceuticals Inc. stock pay reliable dividendsWeekly Trading Summary & Stock Portfolio Risk Control - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

KalVista Pharmaceuticals Inc. stock trend outlook and recovery path2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will KalVista Pharmaceuticals Inc. benefit from macro trendsWeekly Stock Report & AI Enhanced Trade Execution Alerts - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Does KalVista Pharmaceuticals Inc. qualify in momentum factor screening2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Can swing trading help recover from KalVista Pharmaceuticals Inc. lossesBuy Signal & Momentum Based Trading Signals - Newser

Aug 16, 2025
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):